Adalimumab Modulates Angiogenesis in Psoriatic Skin
Angiogenesis plays a key role in the pathogenesis of psoriasis. New blood vessel formation occurs early during plaque lesion development in psoriatic skin, and sometimes precedes disease recurrence. TNF-α, a well established mediator of inflammation in psoriasis, up-regulates the transcription of se...
Main Authors: | A. Campanati, G. Moroncini, G. Ganzetti, K.N. Pozniak, G. Goteri, A. Giuliano, E. Martina, G. Liberati, F. Ricotti, A. Gabrielli, A. Offidani |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-05-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X1301100218 |
Similar Items
-
Adalimumab in treatment of psoriatic arthritis
by: V. V. Badokin
Published: (2008-08-01) -
Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
by: V. V. Didenko, et al.
Published: (2021-05-01) -
THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01) -
Comparative efficacy of tofacitinib and adalimumab in patients with psoriatic arthritis in real clinical practice. Data from the Russian nationwide register of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2021-06-01) -
Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
by: Salvatore D'Angelo, et al.
Published: (2019-12-01)